跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,013 条关于
“ASCO Genitourinary Symposium”
全部
2,013
临床试验
497
药物
109
机构
10
资讯
1,397
去年
Caris Life Sciences to Present Novel Cancer Research at 2025 ASCO GU Symposium
去年
Lenvatinib-Pembrolizumab Combination Shows Promise as First-Line Treatment for Advanced Renal Cell Carcinoma
去年
Lantheus to Present New PYLARIFY Data for Early Prostate Cancer Detection at ASCO GU 2025
去年
Pfizer to Present Landmark Survival Data for Cancer Therapies at ASCO GU 2025 Symposium
去年
Adverse Events Linked to Better Survival Outcomes in Enfortumab Vedotin Treatment for Urothelial Cancer
去年
Corbus Pharmaceuticals Presents Promising Phase 1 Data for Nectin-4 ADC CRB-701 at ASCO GU
去年
Pfizer's Mevrometostat Shows Promising Results in Phase I Prostate Cancer Trial
去年
Novel HIF-2α Inhibitor Casdatifan Shows Promise in Advanced Kidney Cancer Phase 1 Trial
去年
Phase II Trial Shows Breakthrough 63.6% Response Rate for Novel Bladder Cancer Combination Therapy
去年
Blue Light Cystoscopy Reveals Hidden Bladder Tumors, Improves Cancer Staging in Major Registry Study
第 1 页，共 140 页
上一页
下一页
